Skip to main content
. 2021 Apr 17;21(2):169–178. doi: 10.1007/s40268-021-00340-9

Fig. 4.

Fig. 4

Proposed oral dosing regimens. Simulated concentration–time profiles using the pharmacokinetic model for selected oral dosing regimens that achieved the target selenium concentration range demarcated by horizontal gray dashed lines (lower, 395 ng/mL; upper, 790 ng/mL). BID twice daily, TID three times daily